Improving cancer care through clinical trials

Eva Segelov

An INVITATION from the Western Australian Clinical Oncology Group

If you live in, or close to Perth, please join this not to be missed event providing a spotlight on pancreatic, oesophageal and stomach cancers: Improving cancer care through clinical trials

Who : Professor Eva Segelov, GI Cancer Institute Board member and Principal Investigator ICECREAM clinical trial in bowel cancer

What: A spotlight on pancreatic, oesophageal and stomach cancers: Improving cancer care through clinical trials

When: Friday 21 July 2017, 12.30 to 1.30 pm

Where: The WA State Library Theatre, Alexander Library Building, Perth – WA

Upper gastrointestinal (GI) cancers (cancer of the oesophagus, stomach, liver, pancreas, gall bladder and small intestine) are relatively uncommon individually; but when grouped together accounted for a total of 900 new cases in Western Australia in 2014. These cancers are characterised with low 5 year survival rates and improvements in treatment have been slow. Professor Eva Segelov (pictured here) is at the forefront of Australian and international clinical trials seeking to change this.

If you can’t make it to the lecture the slides and audio will be available online afterwards… CLICK HERE to access these.

 

WA Clinical Oncology Group Logo

WA Clinical Oncology Group (WACOG) was formed in 1997 to advise the Cancer Council WA on all clinical aspects of cancer. WACOG also aims to promote and facilitate cooperative studies on cancer.